[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ischemic-left-ventricle-systolic-dysfunction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ischemic-left-ventricle-systolic-dysfunction":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100603243","stich3c-cardiac-magnetic-resonance-observational-study-100603243",false,"NCT07133984","STICH3C Cardiac Magnetic Resonance Observational Study","STICH3C Cardiac Magnetic Resonance (CMR) Observational Study (STICOS)","STICOS","Inclusion Criteria:\n\n1. Men and women ≥ 18 years old\n2. LVEF ≤ 40% (quantified by echo, single-photon emission computed tomography \\[SPECT\\], or CMR within 2 months of enrollment)\n3. Prognostically important CAD: either multivessel CAD (triple vessel or double vessel CAD including left anterior descendant artery (LAD), significant coronary stenosis defined as ≥ 70% based on coronary angiography, fractional flow reserve (FFR) ≤ 0.80 or instantaneous wave-free ratio (iFR) ≤ 0.89) or left main disease (+\u002F- other CAD) for which significant stenosis defined as \\> 50% based on coronary angiography, intravascular ultrasound (IVUS) minimum luminal area \\[MLA\\] value ≤ 6.0 mm2 (\\\u003C 4.5 mm2 Asian descent), or equivalent optical coherence tomography (OCT) measurements.\n4. Planned CABG or PCI within 3 months\n\nExclusion Criteria:\n\n1. Concomitant valve disease or other condition (e.g., LV aneurysm) requiring surgical repair or replacement\n2. Contraindication to CMR (i.e. magnetically activated materials), gadolinium, regadenoson\u002Fadenosine\u002Fdipyridamole\n3. Active neoplasm and\u002For severe end-organ dysfunction with expected life expectancy less than 5 years.\n\n   \\-","ALL","18 Years",{"count":20,"type":21},200,"ESTIMATED","OBSERVATIONAL","STICOS will test the hypothesis that residual jeopardized myocardium, late gadolinium enhancement, and non-ischemic substrate after revascularization is associated with postoperative adverse cardiovascular events such as heart failure , readmission, or death.\n\nThis study will look at whether certain heart tissue abnormalities seen on MRI scans can help predict serious health problems after heart procedures like stents or bypass surgery.",[25,26],"Ischemic Left Ventricle Systolic Dysfunction","Multivessel Coronary Artery Disease",[28,29,30],"iLVSD","CAD","Cardiac MRI","RECRUITING","2025-08-14",{"date":34,"type":35},"2025-08-21","ACTUAL",{"date":37,"type":35},"2024-03-01",{"date":39,"type":21},"2030-01",{"name":41,"class":42},"Weill Medical College of Cornell University","OTHER",9]